Fresenius SE & Co KGaA (FRE) PT Set at €80.00 by Barclays

Share on StockTwits

Barclays set a €80.00 ($93.02) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a research note published on Wednesday morning. The firm currently has a buy rating on the stock.

Several other brokerages have also recently weighed in on FRE. Sanford C. Bernstein set a €83.00 ($96.51) price objective on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Monday, October 8th. HSBC set a €74.00 ($86.05) price objective on Fresenius SE & Co KGaA and gave the company a neutral rating in a research note on Monday, September 3rd. Independent Research set a €80.00 ($93.02) price objective on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, July 31st. DZ Bank restated a neutral rating on shares of Fresenius SE & Co KGaA in a research note on Tuesday, October 2nd. Finally, Goldman Sachs Group set a €66.00 ($76.74) price objective on Fresenius SE & Co KGaA and gave the company a neutral rating in a research note on Monday, October 1st. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the stock. Fresenius SE & Co KGaA currently has an average rating of Buy and an average price target of €76.44 ($88.89).

Shares of FRA:FRE opened at €59.84 ($69.58) on Wednesday. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: The benefits and drawbacks of dollar cost averaging

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Investors Sell Amgen  on Strength After Insider Selling
Investors Sell Amgen on Strength After Insider Selling
Short Interest in Denison Mines Corp  Increases By 35.6%
Short Interest in Denison Mines Corp Increases By 35.6%
Short Interest in Imperial Oil Ltd  Expands By 0.9%
Short Interest in Imperial Oil Ltd Expands By 0.9%
BAE SYS PLC/S  Upgraded to Hold by Zacks Investment Research
BAE SYS PLC/S Upgraded to Hold by Zacks Investment Research
TrueUSD  Price Tops $1.02 on Major Exchanges
TrueUSD Price Tops $1.02 on Major Exchanges
FlappyCoin  Market Capitalization Hits $542,363.00
FlappyCoin Market Capitalization Hits $542,363.00


© 2006-2018 Ticker Report